InsiderClue
Insiders · Profile

Wettig Thane

CEO at KYNTRA BIO. Filing since 26 Aug 2021. CIK 0001815638

Company
Date
Role
Action
Shares
Amount
Of holding
KYNB KYNTRA BIO, INC.
14 May 2026
CEO
Sold at will
2,800
$19.85K
9.3%
KYNB KYNTRA BIO, INC.
17 Nov 2025
CEO
Bought
2,700
$24.57K
12.1%
KYNB KYNTRA BIO, INC.
13 Nov 2025
CEO
Bought
1,000
$9.18K
4.7%
KYNB KYNTRA BIO, INC.
24 Mar 2025
CEO
Bought
145,000
$50.66K
36.4%
KYNB KYNTRA BIO, INC.
7 Mar 2024
CEO
Bought
50,000
$95.47K
11.9%
KYNB KYNTRA BIO, INC.
23 Jun 2023
Chief Commercial Officer
Sold at will
791
$13.07K
0.7%
KYNB KYNTRA BIO, INC.
7 Jun 2023
Chief Commercial Officer
Sold at will
1,758
$29.95K
1.6%
KYNB KYNTRA BIO, INC.
23 Mar 2023
Chief Commercial Officer
Sold at will
905
$16.93K
0.8%
KYNB KYNTRA BIO, INC.
10 Mar 2023
Chief Commercial Officer
Sold, plan not stated
7,669
$154.89K
6.4%
KYNB KYNTRA BIO, INC.
8 Mar 2023
Chief Commercial Officer
Sold, plan not stated
6,265
$132.54K
5.7%
KYNB KYNTRA BIO, INC.
23 Dec 2022
Chief Commercial Officer
Sold, plan not stated
734
$11.60K
0.8%
KYNB KYNTRA BIO, INC.
8 Dec 2022
Chief Commercial Officer
Sold, plan not stated
382
$6.03K
0.4%
KYNB KYNTRA BIO, INC.
26 Aug 2021
Chief Commercial Officer
Bought
3,100
$35.74K
6.8%
13 decisions on file.